Found 0 matching trials
JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma
PHASE2This study is to determine the activity and tolerability of JS207 as a sing...
Location
Department of Clinical Oncology, Prince of Wales Hospital
JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC
PHASE2This is a phase II clinical study to evaluate the safety, tolerability, pre...
Status
Active Not Recruiting
Location
Guangdong Provincial People's Hospital
JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC
PHASE2This study targets patients with in first-line treatment of advanced NSCLC,...
Status
Active Not Recruiting
Location
Shandong First Medical University Affiliated Neoplasm Hospital
JS207 Combination Therapy in Triple-negative Breast Cancer
PHASE2This is an open-label, multi-center, phase II clinical study to preliminari...
Location
Anhui Provincial Cancer Hospital
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
PHASE2This is a multiple-arm, open phase II clinical trial evaluating the safety,...
Location
Beijing Chest Hospital, Capital Medical University
The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor
PHASE1This is a Phase I open-label, multicenter study to evaluate the safety, tol...
Status
Active Not Recruiting
Location
Affiliated Cancer Hospital of Shandong First Medical University